Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Tables)

v3.19.3
Stockholders' Deficit (Tables)
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Nonvested Restricted Stock Shares Activity
Restricted stock activity for the nine months ended September 30, 2019 is summarized as follows:
Number of
Shares
Weighted-
Average
Grant Date
Fair Value
Outstanding at December 31, 2018 127,500    $ 3.21   
Outstanding at Granted 200,000    11.54   
Outstanding at Vested (156,666)   4.76   
Outstanding at Outstanding at September 30, 2019 170,834    $ 11.54   
Stock Option Activity
The following table summarizes stock option activities for the nine months ended September 30, 2019:
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining Life
(in Years)
Aggregate
Intrinsic
Value
Outstanding, December 31, 2018 2,235,000    $ 1.74    9.44 $ 23,100   
Granted 608,550    5.70   
Exercised —    —   
Cancelled —    —   
Outstanding, September 30, 2019 2,843,550    $ 2.59    8.85 $ 23,040,551   
Exercisable, September 30, 2019 767,125    $ 1.73    8.86 $ 6,876,323   
Warrants Activity
The following table summarizes warrant activity for the nine months ended September 30, 2019:
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual
Term
(in Years)
Aggregate
Intrinsic
Value
Outstanding, December 31, 2018 776,350    $ 1.75    4.80 $ —   
Granted 924,581    9.73   
Exercised (644,028)   2.15    5,500,609   
Forfeited (cashless exercise) (168,570)   4.06   
Outstanding, September 30, 2019 888,333    $ 9.33    4.46 $ 1,208,572   
Exercisable, September 30, 2019 888,333    $ 9.33    4.46 $ 1,208,572